Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-28 LEWIS JOEL President and CEO Grant or award +9,358 $1.87 $17K 437.94
2022-02-15 LEWIS JOEL President and CEO Grant or award +8,454 $2.07 $17K 428,585
2022-02-02 10X Fund, L.P. 10% owner Sale −10,000 $2.10 $21K 6,178,940
2022-01-31 LEWIS JOEL President and CEO Grant or award +112,263 $1.93 $217K 420,131
2022-01-24 Uihlein Richard E Director Grant or award +17,677 $1.98 $35K 7,936,677
2022-01-24 Uihlein Richard E Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 Schwartz Elissa J. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 Shlevin Harold H. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 ELDRED KARY Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 CZIRR JAMES C Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 Rubin Marc Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 OMENN GILBERT S Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 Zordani Richard A. Jr. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 AMELIO GILBERT F Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-01-24 CALLICUTT JACK W Chief Financial Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2022-01-24 Boudes Pol F Chief Medical Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2022-01-24 LEWIS JOEL President and CEO Grant or award · Stock Option (right to buy) +70,000 70,000
2022-01-21 Schwartz Elissa J. Director Purchase +1,000 $2.00 $2K 1,000
2022-01-19 FREEMAN KEVIN D Director Purchase +5,000 $1.96 $10K 55,000

Page 20 of 21 · 404 trades